Thanks JTFM. Can't be a coincidence that the completion of the follow-up occurs with the abandonment of the original applications and filing of the new continuation-in-parts in early October.
Another dot we have not discussed in a while is Abbott's Architect Testosterone testing platform. They have a lot to gain from broad prescription of testosterone and the required frequent testing behind it.
News 
Market Data 
Discover 
